Geschäft · 20.7.20181 Min. Lesezeit
Metered Dose Inhaler and Dry Powder Inhaler Drug Products-Quality Considerations; Draft Guidance for Industry; Reopening of the Comment Period
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA, Agency, or we) is reopening the comment period for the "Metered Dose Inhaler and Dry Powder Inhaler Drug Products--Quality Considerations; Draft Guidance for Industry," published in the Federal Register of April 19, 2018. FDA is reopening the comment period to allow interested persons additional time to submit comments.